Concepedia

Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients

Manel Sabaté, Pilar Jiménez‐Quevedo, Dominick J. Angiolillo

Circulation · 2005 · 366 citations · 20 references

DOIFull text

Open access

Abstract

This randomized trial demonstrated that sirolimus stent implantation is safe and efficacious in reducing both angiographic and clinical parameters of restenosis compared with standard stents in diabetic patients with de novo coronary stenoses.

References

20

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

K. G. M. M. Alberti, Paul Zimmet · Diabetic Medicine · 1998 · 15.2K citations

Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections

Hilary King, Ronald E. Aubert, William H. Herman · Diabetes Care · 1998 · 6.3K citations

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma et al. · New England Journal of Medicine · 2003 · 4.2K citations · Full text

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

Marie‐Claude Morice, Patrick W. Serruys, J. Eduardo Sousa et al. · New England Journal of Medicine · 2002 · 4K citations · Full text

A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease

Gregg W. Stone, Stephen G. Ellis, David A. Cox et al. · New England Journal of Medicine · 2004 · 2.7K citations · Full text